Nucana (NCNA) Fundamental Analysis: Revenue, Earnings & Valuation

4.52 / 10

Netural

Fundamentally, Nucana rates 4.5/10. Strong points include a high interest coverage ratio and positive Revenue‑MV, while inventory turnover and revenue growth are robust. Weaknesses are a high current‑liabilities‑to‑total‑liabilities ratio and poor PB‑ROE, yielding a neutral outlook.

Analysis Checks(7/10)

Revenue-MV

Value-0.11

Score3/3

Weight98.69%

1M Return8.11%

Total operating revenue (YoY growth rate %)

Value134.00

Score2/3

Weight1.36%

1M Return0.13%

Inventory turnover ratio

Value103.94

Score2/3

Weight-11.25%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value87.03

Score0/3

Weight-41.70%

1M Return-4.96%

PB-ROE

Value44.98

Score0/3

Weight33.25%

1M Return2.74%

Long-term debt to working capital ratio (%)

Value0.03

Score2/3

Weight-3.49%

1M Return-0.35%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-11.44%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value177.16

Score2/3

Weight0.55%

1M Return0.05%

Cost of sales ratio (%)

Value64.41

Score2/3

Weight-10.81%

1M Return-1.13%

Asset-MV

Value-0.55

Score0/3

Weight44.85%

1M Return4.00%

Is NCNA undervalued or overvalued?

NCNA scores 4.52/10 on fundamentals and holds a Fair valuation at present. Backed by its -193.87% ROE, 0.00% net margin, -0.16 P/E ratio, 0.20 P/B ratio, and 100.00% earnings growth, these metrics solidify its Netural investment rating.